|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||
| Total cash and cash equivalents | |||||||||||
| Bank deposits | |||||||||||
| Total bank deposits | |||||||||||
| Restricted deposits | |||||||||||
| Total restricted deposits | |||||||||||
| Trade receivables | |||||||||||
| Total trade receivables | |||||||||||
| Other receivables | |||||||||||
| Total other receivables | |||||||||||
| Inventory | |||||||||||
| Total inventory | |||||||||||
| Current assets | |||||||||||
| Total current assets | |||||||||||
| Investment in securities | |||||||||||
| Property plant and equipment, net | |||||||||||
| Total property plant and equipment, net | |||||||||||
| Right-of-use assets | |||||||||||
| Intangible assets | |||||||||||
| Total intangible assets | |||||||||||
| Non-current assets | |||||||||||
| Total non-current assets | |||||||||||
| Assets | |||||||||||
| Total assets | |||||||||||
| Trade payables | |||||||||||
| Total trade payables | |||||||||||
| Other payables | |||||||||||
| Total other payables | |||||||||||
| Current portion of other long-term liability | |||||||||||
| Current portion of lease liability | |||||||||||
| Current portion of bank loan | |||||||||||
| Current liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Liability in respect of government grants | |||||||||||
| Total liability in respect of government grants | |||||||||||
| Employee benefits | |||||||||||
| Lease liability | |||||||||||
| Deferred tax liabilities | |||||||||||
| Loan from banks | |||||||||||
| Total loan from banks | |||||||||||
| Bank loan | |||||||||||
| Non-current liabilities | |||||||||||
| Total non-current liabilities | |||||||||||
| Liabilities | |||||||||||
| Total liabilities | |||||||||||
| Non-controlling interests | |||||||||||
| Share capital | |||||||||||
| Total share capital | |||||||||||
| Share premium and capital reserves | |||||||||||
| Total share premium and capital reserves | |||||||||||
| Treasury shares | |||||||||||
| Total treasury shares | |||||||||||
| Foreign currency translation reserve | |||||||||||
| Remeasurement of net defined benefit liability (IAS 19) | |||||||||||
| Accumulated loss | |||||||||||
| Total accumulated loss | |||||||||||
| Equity attributable to owners of the Company | |||||||||||
| Equity | |||||||||||
| Total equity | |||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Bank deposits | |||||||||||
| Marketable equity securities | |||||||||||
| Restricted bank deposits | |||||||||||
| Trade receivables, net of allowance for doubtful accounts ($950 and $861, respectively) | |||||||||||
| Inventory | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Restricted bank deposits | |||||||||||
| Marketable equity securities | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Deferred tax assets | |||||||||||
| Goodwill | |||||||||||
| Intangible assets, net | |||||||||||
| Other assets | |||||||||||
| Total assets | |||||||||||
| Liabilities and Equity | |||||||||||
| Current liabilities: | |||||||||||
| Trade payables | |||||||||||
| Accrued liabilities | |||||||||||
| Deferred Revenue | |||||||||||
| Current portion of lease liability | |||||||||||
| Current portion of bank loan | |||||||||||
| Total current liabilities | |||||||||||
| Employee benefits | |||||||||||
| Operating lease right-of-use liabilities | |||||||||||
| Bank loan | |||||||||||
| Long-term settlement payable | |||||||||||
| Long-term deferred revenue | |||||||||||
| Total liabilities | |||||||||||
| Non-controlling interests | |||||||||||
| Equity: | |||||||||||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 210,589,406 and 206,811,875 shares outstanding as of June 30, 2026 and December 31, 2025, respectively, and 283,084,053 and 279,306,522 shares issued as of June 30, 2026 and December 31, 2025, respectively. | |||||||||||
| Additional paid-in capital | |||||||||||
| Treasury stock | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Accumulated Loss | |||||||||||
| Total equity attributable to common shareholders | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity | |||||||||||
Loading...